MSF Field Research >
1 Published Research and Commentary >
Trypanosomiasis/Sleeping Sickness >
Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo.
this identifier to cite or link
to this item:
|Title: ||Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo.|
|Affiliation: ||Médecins Sans Frontières, Rue de Lausanne 78, 1211 Geneva, Switzerland. firstname.lastname@example.org.|
|Citation: ||Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo. 2011, 5:7 Confl Health|
|Publisher: ||BioMed Central|
|Journal: ||Conflict and Health|
|Issue Date: ||26-May-2011 |
|PubMed ID: ||21615932|
|Additional Links: ||http://www.conflictandhealth.com/content/5/1/7|
|Abstract: ||Human African trypanosomiasis (HAT), or sleeping sickness, is a fatal neglected tropical disease if left untreated. HAT primarily affects people living in rural sub-Saharan Africa, often in regions afflicted by violent conflict. Screening and treatment of HAT is complex and resource-intensive, and especially difficult in insecure, resource-constrained settings. The country with the highest endemicity of HAT is the Democratic Republic of Congo (DRC), which has a number of foci of high disease prevalence. We present here the challenges of carrying out HAT control programmes in general and in a conflict-affected region of DRC. We discuss the difficulties of measuring disease burden, medical care complexities, waning international support, and research and development barriers for HAT.|
|MeSH: ||Trypanosomiasis, African|
|Rights: ||Archived with thanks to Conflict and Health|
|Appears in topics: ||Trypanosomiasis/Sleeping Sickness|
|Related articles on PubMed|
Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo.
Mpanya A, Hendrickx D, Vuna M, Kanyinda A, Lumbala C, Tshilombo V, Mitashi P, Luboya O, Kande V, Boelaert M, Lefèvre P, Lutumba P
|See all 109 articles|
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.